HMG-CoA reductase inhibitors (statins)

A promising approach to stroke prevention

David C Hess, Andrew M. Demchuk, Lawrence M. Brass, Frank M. Yatsu

Research output: Contribution to journalReview article

107 Citations (Scopus)

Abstract

Statins represent a promising class of agents to prevent stroke. In randomized trials of middle-aged patients with coronary artery disease, statins reduce the incidence of stroke. The reduction in stroke may not be solely related to cholesterol or low-density lipoprotein reduction but may involve nonsterol mechanisms effects on endothelia cells, macrophages, platelets, and smooth muscle cells. Statins also reduce the size of cerebral infarction in a murine stroke model, suggesting a neuroprotective effect. The best current evidence for stroke prevention is with pravastatin and simvastatin. Pravastatin reduces the risk of stroke in patients with coronary artery disease and average cholesterol levels simvastatin reduces the risk of the combined endpoint of stroke and transient ischemic attack in hypercholesterolemic patients with coronary artery disease. Future studies of statins are needed in stroke populations, particularly the elderly.

Original languageEnglish (US)
Pages (from-to)790-796
Number of pages7
JournalNeurology
Volume54
Issue number4
DOIs
StatePublished - Feb 22 2000

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Stroke
Coronary Artery Disease
Pravastatin
Simvastatin
Transient Ischemic Attack
Cerebral Infarction
Neuroprotective Agents
LDL Cholesterol
Smooth Muscle Myocytes
Endothelium
Blood Platelets
Macrophages
Cholesterol
Incidence

Keywords

  • Cholesterol
  • CoA reductase inhibitors
  • HMG
  • Prevention
  • Statins
  • Stroke

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

HMG-CoA reductase inhibitors (statins) : A promising approach to stroke prevention. / Hess, David C; Demchuk, Andrew M.; Brass, Lawrence M.; Yatsu, Frank M.

In: Neurology, Vol. 54, No. 4, 22.02.2000, p. 790-796.

Research output: Contribution to journalReview article

Hess, David C ; Demchuk, Andrew M. ; Brass, Lawrence M. ; Yatsu, Frank M. / HMG-CoA reductase inhibitors (statins) : A promising approach to stroke prevention. In: Neurology. 2000 ; Vol. 54, No. 4. pp. 790-796.
@article{7c8b7ae720df4d399aba285a8bd29231,
title = "HMG-CoA reductase inhibitors (statins): A promising approach to stroke prevention",
abstract = "Statins represent a promising class of agents to prevent stroke. In randomized trials of middle-aged patients with coronary artery disease, statins reduce the incidence of stroke. The reduction in stroke may not be solely related to cholesterol or low-density lipoprotein reduction but may involve nonsterol mechanisms effects on endothelia cells, macrophages, platelets, and smooth muscle cells. Statins also reduce the size of cerebral infarction in a murine stroke model, suggesting a neuroprotective effect. The best current evidence for stroke prevention is with pravastatin and simvastatin. Pravastatin reduces the risk of stroke in patients with coronary artery disease and average cholesterol levels simvastatin reduces the risk of the combined endpoint of stroke and transient ischemic attack in hypercholesterolemic patients with coronary artery disease. Future studies of statins are needed in stroke populations, particularly the elderly.",
keywords = "Cholesterol, CoA reductase inhibitors, HMG, Prevention, Statins, Stroke",
author = "Hess, {David C} and Demchuk, {Andrew M.} and Brass, {Lawrence M.} and Yatsu, {Frank M.}",
year = "2000",
month = "2",
day = "22",
doi = "10.1212/WNL.54.4.790",
language = "English (US)",
volume = "54",
pages = "790--796",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - HMG-CoA reductase inhibitors (statins)

T2 - A promising approach to stroke prevention

AU - Hess, David C

AU - Demchuk, Andrew M.

AU - Brass, Lawrence M.

AU - Yatsu, Frank M.

PY - 2000/2/22

Y1 - 2000/2/22

N2 - Statins represent a promising class of agents to prevent stroke. In randomized trials of middle-aged patients with coronary artery disease, statins reduce the incidence of stroke. The reduction in stroke may not be solely related to cholesterol or low-density lipoprotein reduction but may involve nonsterol mechanisms effects on endothelia cells, macrophages, platelets, and smooth muscle cells. Statins also reduce the size of cerebral infarction in a murine stroke model, suggesting a neuroprotective effect. The best current evidence for stroke prevention is with pravastatin and simvastatin. Pravastatin reduces the risk of stroke in patients with coronary artery disease and average cholesterol levels simvastatin reduces the risk of the combined endpoint of stroke and transient ischemic attack in hypercholesterolemic patients with coronary artery disease. Future studies of statins are needed in stroke populations, particularly the elderly.

AB - Statins represent a promising class of agents to prevent stroke. In randomized trials of middle-aged patients with coronary artery disease, statins reduce the incidence of stroke. The reduction in stroke may not be solely related to cholesterol or low-density lipoprotein reduction but may involve nonsterol mechanisms effects on endothelia cells, macrophages, platelets, and smooth muscle cells. Statins also reduce the size of cerebral infarction in a murine stroke model, suggesting a neuroprotective effect. The best current evidence for stroke prevention is with pravastatin and simvastatin. Pravastatin reduces the risk of stroke in patients with coronary artery disease and average cholesterol levels simvastatin reduces the risk of the combined endpoint of stroke and transient ischemic attack in hypercholesterolemic patients with coronary artery disease. Future studies of statins are needed in stroke populations, particularly the elderly.

KW - Cholesterol

KW - CoA reductase inhibitors

KW - HMG

KW - Prevention

KW - Statins

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=0034701033&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034701033&partnerID=8YFLogxK

U2 - 10.1212/WNL.54.4.790

DO - 10.1212/WNL.54.4.790

M3 - Review article

VL - 54

SP - 790

EP - 796

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 4

ER -